Propanc Biopharma, Inc. (PPCB) — S-1/A Filings

S-1/A Filings (6)

• Propanc Biopharma Amends S-1/A, Deepens Losses Amid R&D Push — Jul 28, 2025 Risk: high
  Propanc Biopharma, Inc. (PPCB) filed an S-1/A on July 28, 2025, indicating a continued focus on its biopharmaceutical development without reporting revenue for
• Propanc Biopharma Amends S-1/A, Details Capital Structure — May 30, 2025 Risk: high
  Propanc Biopharma, Inc. (PPCB) filed an S-1/A on May 30, 2025, indicating continued operations as a pharmaceutical preparations company. The filing covers the p
• Propanc Biopharma Files S-1/A Amendment — Apr 25, 2025 Risk: medium
  Propanc Biopharma, Inc. filed an S-1/A amendment on April 25, 2025, detailing its financial status and business operations. The company, previously known as Pro
• Propanc Biopharma Files S-1/A — Apr 8, 2025 Risk: medium
  Propanc Biopharma, Inc. filed an S-1/A on April 8, 2025, detailing its business and financial status. The company, incorporated in Delaware, operates in the pha
• Propanc Biopharma Files S-1/A — Apr 2, 2025 Risk: medium
  Propanc Biopharma, Inc. filed an S-1/A on April 2, 2025, detailing its business and financial status. The company, previously known as Propanc Health Group Corp
• Propanc Biopharma Files S-1/A — Mar 31, 2025 Risk: medium
  Propanc Biopharma, Inc. filed an S-1/A on March 31, 2025, detailing its financial status and business operations. The company, incorporated in Delaware, operate

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX